Gas Mixture Improves Efficacy of Breakthrough Cancer Pain Treatment

Share this content:
In this study, patients experiencing breakthrough pain were randomly assigned to receive, in addition to immediate-release morphine sulphate, a nitrous oxide/oxygen mixture.
In this study, patients experiencing breakthrough pain were randomly assigned to receive, in addition to immediate-release morphine sulphate, a nitrous oxide/oxygen mixture.

Self-administration of a nitrous oxide/oxygen mixture may be more effective than oxygen alone as an adjunct analgesic treatment in reducing moderate to severe breakthrough cancer pain, according to results from a double-blind randomized clinical trial published in the European Journal of Pain.

A total of 240 people with cancer who were experiencing breakthrough pain were randomly assigned to receive, in addition to immediate-release morphine sulphate, a nitrous oxide/oxygen mixture (n=180) or oxygen (n=60). Pain was assessed with the 0 to 10 numeric rating scale at baseline, at 5 and 15 minutes after the start of treatment, and 5 minutes after treatment.

Baseline pain scores were comparable in both treatment groups (6.6±1.2 in patients treated with the mixture vs 6.6±1.3 in patients receiving oxygen). Pain reduction was greater in patients receiving the gas mixture vs oxygen alone at 5 minutes after administration (2.8±1.3 vs 5.5±1.2, respectively; P <.01) and at 15 minutes (2.0±1.1 vs 5.6±1.3, respectively; P <.01).

In addition, patient satisfaction was found to be higher in the nitrous oxide/oxygen group compared with the oxygen group (P <.01). Although a greater percentage of patients administered the gas mixture vs oxygen alone experienced nausea (13.9% vs 11.7%, respectively), no significant overall differences between the 2 groups was observed with regard to adverse events.

The nitrous oxide/oxygen mixture “can be used widely in low-resource settings because it exhibits analgesic properties and causes a low incidence of side effects,” noted the investigators.

Reference

Liu Q, Gao LL, Dai YL, et al. Nitrous oxide/oxygen mixture for analgesia in adult cancer patients with breakthrough pain: a randomized, double-blind controlled trial [published online December 11, 2017]. Eur J Pain. doi: 10.1002/ejp.1144

You must be a registered member of ONA to post a comment.

Sign Up for Free e-newsletters



Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs